Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FRW94
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,452
Award facts
- Contract value 100% obligated
- $5,451.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,451.63 to AmerisourceBergen Drug Corp for XELJANZ XR 11 mg tablets (30-unit packages) on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. XELJANZ XR is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, representing a routine pharmaceutical supply fulfillment for federal healthcare needs.
This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999 million and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs and other federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's position as a major pharmaceutical distributor and the competitively awarded nature of its contracts demonstrate its established capability to meet federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FRW94?
SPE2DB25FRW94 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FRW94 worth?
The government has obligated $5,452 on SPE2DB25FRW94.
Is contract SPE2DB25FRW94 an order under another contract?
Yes. SPE2DB25FRW94 is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FRW94 competed?
The extent of competition for SPE2DB25FRW94 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award